Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC
Clinical trial NCT03990077 · TERMINATED
Trial details
- NCT number
- NCT03990077
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2021-07-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.